Literature DB >> 2282946

Comparing clinical tests of visual function in cataract with the patient's perceived visual disability.

D B Elliott1, M A Hurst, J Weatherill.   

Abstract

Conventional techniques for assessing the visual function of cataract patients include visual acuity (VA), contrast sensitivity (CS) and glare disability (GD). The extent to which these measurements provide accurate information about a patient's perceived visual disability is not known. In this study, binocular and monocular VA and CS and monocular GD measurements were made using commercially available techniques on 33 cataract patients. VA was measured using a Ferris-Bailey LogMAR chart and CS by the Pelli-Robson letter CS chart. Glare disability was measured using the Mentor Brightness Acuity Tester in conjunction with both the LogMAR and Pelli Robson charts. Each patient's perceived visual disability was quantified using a 20-point questionnaire about the effect of vision on everyday activities. There was little correlation between subjective visual disability and monocular or binocular VA measurements. Measurements of binocular CS, however, were highly correlated with the patient's perceived visual disability, particularly their subjective assessment of the effect of vision on their mobility-orientation. We suggest that binocular CS measurements using the Pelli-Robson chart provide useful additional information regarding the need for surgery in cataract patients.

Entities:  

Mesh:

Year:  1990        PMID: 2282946     DOI: 10.1038/eye.1990.100

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  48 in total

1.  Visual function after penetrating keratoplasty for keratoconus: a prospective longitudinal evaluation.

Authors:  A Brahma; F Ennis; R Harper; A Ridgway; A Tullo
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

Review 2.  Management of cataract.

Authors:  R Dickson; A Eastwood; P Gill; A Melville; S O'Meara; T Sheldon
Journal:  Qual Health Care       Date:  1996-09

3.  Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device.

Authors:  L Tejeria; R A Harper; P H Artes; C M Dickinson
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

4.  Contrast sensitivity after intravitreal antivascular endothelial growth factor therapy for myopic choroidal neovascularization.

Authors:  Sarah Moussa; Siamak Ansari-Shahrezaei; Eva Smretschnig; Stefan Hagen; Kerstin Steindl-Kuscher; Ilse Krebs; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-16       Impact factor: 3.117

5.  Measurement of stray light and glare: comparison of Nyktotest, Mesotest, stray light meter, and computer implemented stray light meter.

Authors:  L J van Rijn; C Nischler; D Gamer; L Franssen; G de Wit; R Kaper; D Vonhoff; G Grabner; H Wilhelm; H J Völker-Dieben; T J T P van den Berg
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

6.  Genetic influence on contrast sensitivity in middle-aged male twins.

Authors:  Alice Cronin-Golomb; Matthew S Panizzon; Michael J Lyons; Carol E Franz; Michael D Grant; Kristen C Jacobson; Seth A Eisen; Thomas M Laudate; William S Kremen
Journal:  Vision Res       Date:  2007-06-29       Impact factor: 1.886

Review 7.  On the relation between glare and straylight.

Authors:  T J van den Berg
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

8.  The impact of penetrating keratoplasty in patients with keratoconus using the VF-14 questionnaire.

Authors:  N Ziakas; E Kanonidou; D Mikropoulos; N Georgiadis
Journal:  Int Ophthalmol       Date:  2011-01-26       Impact factor: 2.031

9.  An instrument for assessment of subjective visual disability in cataract patients.

Authors:  K Pesudovs; D J Coster
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

10.  Do patients with age related maculopathy and cataract benefit from cataract surgery?

Authors:  G N Shuttleworth; E A Luhishi; R A Harrad
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.